| Serial Number | 97023419 |
| Word Mark | METRODORA |
| Filing Date | Sunday, September 12, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Wednesday, October 1, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 28, 2023 |
| Goods and Services | Pharmaceuticals for the treatment of complex or rare multisystem disorders, namely, autoimmune disorders, autonomic nervous system disorders, microbiota-gut-brain axis disorders, concussions, connective tissue disorders, dysautonomia, gastrointestinal disorders, gastrointestinal motility disorders, genetic disorders, headaches, immunological disorders, neurocognitive disorders, neurological disorders, neurogastrointestinal disorders, pain, post-traumatic stress disorder, rheumatic disorders, or traumatic brain injuries; pharmaceutical preparations for the treatment of complex or rare multisystem disorders, namely, autoimmune disorders, autonomic nervous system disorders, microbiota-gut-brain axis disorders, concussions, connective tissue disorders, dysautonomia, gastrointestinal disorders, gastrointestinal motility disorders, genetic disorders, headaches, immunological disorders, neurocognitive disorders, neurological disorders, neurogastrointestinal disorders, pain, post-traumatic stress disorder, rheumatic disorders, or traumatic brain injuries; therapeutic pharmaceuticals for the treatment of complex or rare multisystem disorders, namely, autoimmune disorders, autonomic nervous system disorders, microbiota-gut-brain axis disorders, concussions, connective tissue disorders, dysautonomia, gastrointestinal disorders, gastrointestinal motility disorders, genetic disorders, headaches, immunological disorders, neurocognitive disorders, neurological disorders, neurogastrointestinal disorders, pain, post-traumatic stress disorder, rheumatic disorders, or traumatic brain injuries; medical preparations for the treatment of complex or rare multisystem disorders, namely, autoimmune disorders, autonomic nervous system disorders, microbiota-gut-brain axis disorders, concussions, connective tissue disorders, dysautonomia, gastrointestinal disorders, gastrointestinal motility disorders, genetic disorders, headaches, immunological disorders, neurocognitive disorders, neurological disorders, neurogastrointestinal disorders, pain, post-traumatic stress disorder, rheumatic disorders, or traumatic brain injuries; prescription diets, namely, dietetic foods and nutritional and dietary supplements provided by prescription for the treatment of complex or rare multisystem disorders, namely, autoimmune disorders, autonomic nervous system disorders, microbiota-gut-brain axis disorders, concussions, connective tissue disorders, dysautonomia, gastrointestinal disorders, gastrointestinal motility disorders, genetic disorders, headaches, immunological disorders, neurocognitive disorders, neurological disorders, neurogastrointestinal disorders, pain, post-traumatic stress disorder, rheumatic disorders, or traumatic brain injuries |
| Pseudo Mark | METRO DORA |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 20, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Metrodora Institute LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Salt Lake City, UT 84103 |
| Party Name | Metrodora Institute LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Salt Lake City, UT 84103 |
| Event Date | Event Description |
| Wednesday, October 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, September 15, 2021 | NEW APPLICATION ENTERED |
| Wednesday, June 15, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 23, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, June 23, 2022 | NON-FINAL ACTION E-MAILED |
| Thursday, June 23, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 22, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 22, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 23, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 3, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, February 3, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, February 3, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, February 3, 2023 | ASSIGNED TO LIE |
| Friday, February 3, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 17, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 8, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 28, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 28, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 23, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 14, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 14, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, November 14, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, November 16, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, May 23, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, May 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 1, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, October 1, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Thursday, May 23, 2024 | SOU EXTENSION 2 FILED |
| Thursday, May 23, 2024 | SOU TEAS EXTENSION RECEIVED |